Company intelligence / Profile preview

Somatix

New York, New York, United Statessomatix.com ↗

Ownership: Private
Development stage: Other

Overview

Somatix’s SafeBeing platform is commercially available and has demonstrated utility in real-world deployments, including medication compliance and hydration tracking for dementia patients as part of collaborations with Roche Pharmaceuticals. The SmokeBeat program is used for passive smoking cessation support. Clinical results focus on improved adherence, early risk detection, and actionable insights for providers.

Therapeutic areas: NephrologyPsychiatryNeurologyOther
Modalities: DeviceNon-pharmacological therapyDigital health platform (AI-powered remote monitoring)
Industry: Digital Health Medical Devices

Partnerships

Roche Pharmaceuticals ("Building Tomorrow Together" initiative)Multicare Portugal/Beta-i Collaborative Innovation ProgramPremier WirelessT-Mobile 5G AcceleratorLG NOVA accelerator program participant/investor

Beyond the preview

Go deeper on Somatix.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Somatix.

Explore the full profile